ROIX

Response Oncology, Inc. ROIX

Trading inactive

ROIX
Response Oncology, Inc. GNRS
The Greenrose Holding Company Inc. QMED
QMed, Inc. SYNI
Synvista Therapeutics, Inc. VTEQ
VeriTeQ Corporation LHRP
LifeHOUSE Holdings, LLC RFCS
Refocus Group, Inc.

Résultat net

EBITDA

P/E Ratio

Capitalisation

Performance

Periode ROIX GNRS QMED SYNI VTEQ LHRP RFCS
6M 0.00 % -85.71 % -99.00 % 0.00 % 0.00 % 0.00 % -99.99 %
YTD 0.00 % -85.71 % 0.00 % 0.00 % 0.00 % 0.00 % 0.00 %
1Y 0.00 % -99.97 % 0.00 % 0.00 % -100.00 % 0.00 % -99.99 %
3Y 0.00 % -100.00 % -99.00 % -99.00 % -100.00 % -99.00 % -100.00 %
5Y -90.00 % -100.00 % -99.00 % -99.67 % -100.00 % -99.00 % -100.00 %
10Y -99.00 % -100.00 % -99.96 % -99.00 % -100.00 % -99.00 % -100.00 %
Depuis le début -100.00 % -100.00 % -100.00 % -100.00 % -100.00 % -99.00 % -100.00 %

Dividende